Patents by Inventor Ramesh U. BATWAL

Ramesh U. BATWAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230174985
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Application
    Filed: January 27, 2023
    Publication date: June 8, 2023
    Inventors: Danith H. LY, Shivaji A. THADKE, Ramesh U. BATWAL, Dietrich A. STEPHAN
  • Patent number: 11603530
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 14, 2023
    Assignee: NEUBASE THERAPEUTICS, INC.
    Inventors: Danith H. Ly, Shivaji A. Thadke, Ramesh U. Batwal, Dietrich A. Stephan
  • Publication number: 20220324914
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 13, 2022
    Inventors: Danith H. LY, Shivaji A. THADKE, Ramesh U. BATWAL, Valentina DI CARO, Dietrich A. STEPHAN, Letha J. SOOTER, Samuel I. BACKENROTH
  • Publication number: 20220112238
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Application
    Filed: April 15, 2021
    Publication date: April 14, 2022
    Inventors: Danith H. LY, Shivaji A. THADKE, Ramesh U. BATWAL, Valentina DI CARO, Dietrich A. STEPHAN, Letha J. SOOTER, Samuel I. BACKENROTH
  • Publication number: 20210324012
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 21, 2021
    Inventors: Danith H. LY, Shivaji A. THADKE, Ramesh U. BATWAL, Valentina DI CARO, Dietrich A. STEPHAN, Letha J. SOOTER, Samuel I. BACKENROTH
  • Publication number: 20210309997
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Application
    Filed: March 30, 2021
    Publication date: October 7, 2021
    Inventors: Danith H. LY, Shivaji A. THADKE, Ramesh U. BATWAL, Valentina DI CARO, Dietrich A. STEPHAN, Letha J. SOOTER, Samuel I. BACKENROTH
  • Publication number: 20210309700
    Abstract: The present disclosure relates to compounds useful for the detection or modulation of target nucleic acids, including DNA and RNA. The present disclosure further relates to methods for treatment of trinucleotide repeat disorders, which can include administration of oligonucleotide analogues that can bind pathogenic nucleotide repeats in DNA or RNA.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 7, 2021
    Inventors: Danith H. LY, Shivaji A. THADKE, Ramesh U. BATWAL, Valentina DI CARO, Dietrich A. STEPHAN, Letha J. SOOTER, Samuel I. BACKENROTH